Preimplantation Genetic Testing for Aneuploidies

Helping you have a successful pregnancy and a healthy baby by selecting chromosomally normal embryos

Order Now

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.


  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.


It's very important to identify embryos with the correct number 
of chromosomes for successful fertility treatment.


Complete analysis of all 24 chromosomes


12-hour procedure


Results in more than 99% of cases


More than 20 years' experience in genetics

Advanced Reproductive Genetic Services


PGT-A (formerly PGS) is a genetic study of the embryo produced during IVF treatment and can help you have a healthy baby. The PGT-A test:

  • Is performed on the embryo before it is transferred.
  • Allows the identification and transfer of embryos free from aneuploidies to the mother.
  • Significantly increases pregnancy rates per transfer.
  • Reduces the time needed to achieve pregnancy.
Who should use PGS test?

Who should use PGT-A test?

PGT-A is especially recommended for:

  • ADVANCED MATERNAL AGE: 35 years and above.
  • RECURRENT MISCARRIAGES: women with two or more miscarriages.
  • IVF failures: two or more IVF failures .
  • MALE FACTOR: considering a low quantity and/or quality of sperm.


  • Reduced miscarriage rates.
  • Higher pregnancy rates per transfer.
  • Fewer cycles of IVF treatment needed (less time and money).
  • Greater chance of having a healthy child.
  • Fewer wasted transfers (implantation failure).
Watch Now

How it works

PGT-A Methodology

Patient stories

“You all helped me to make my dream of being a mother come true"

Read more stories


For further assistance please contact our customer support team by phone or e-mail


Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.